Depression is a common condition that has a significant disease burden on those affected. While medication and psychotherapy ...

not including patients with bipolar disorder and/or not reporting on correlations between electronic mood self-monitoring and validated clinical rating scales for depression and mania or the ...

The other is a standardized symptom rating scale that assesses patient standing on each of the constellation of symptoms of depression, from personal outlook to physical slowness. Has the veil on ...

Primary efficacy measures were the Hamilton and the Montgomery-Asberg rating scales for depression. Results: Overall, there was a significant reduction in both primary efficacy measure scores at ...

Results—At the end of the training programme, there was a clinically relevant and statistically significant reduction in depression scores (Hamilton Rating Scale for Depression: before, 19.5 (3.3); ...

Supernus Pharmaceutical’s stock declined following the release of disappointing Phase IIb trial results for SPN-820, an investigational treatment for adults with treatment-resistant depression (TRD).

Supernus Pharmaceuticals said on Tuesday its depression treatment trial failed to meet the main goal of reduction in depressive symptoms, sending its shares down 20% aftermarket. The company said the ...